In Zucker fatty rats, BT2 rapidly lowers hepatic triglycerides and improves glucose tolerance and insulin sensitivity (White et al., 2018), and treatment of ob/ob and diet‐induced obese mice with BT2 restores BCAA catabolism and is sufficient to improve glucose tolerance and insulin resistance (Zhou et al., 2019). The gene discussed is INS; the disease is Insulin resistance.